Rapid Lung Function Improvement with Lebrikizumab in Patients with Uncontrolled Asthma
Corren, Jonathan, MD, Hanania, Nicola A., MD, Korenblat, Phillip E., MD, FAAAAI, Olssen, Julie K., MD, MS, Kamath, Nikhil, MD, Gray, Sarah, PhD, Martin, Nicolas, Holweg, Cecile T.J., PhD, Matthews, John G., MB, BS, MRSCP, PhD, Limb, Susan L., MD, Korom, Stephan
Published in Journal of allergy and clinical immunology (01.02.2016)
Published in Journal of allergy and clinical immunology (01.02.2016)
Get full text
Journal Article
Type 2 Biomarkers Define a Prevalent Phenotype in Moderate-to-Severe, Uncontrolled Asthma Patients: A Pooled Analysis from Lebrikizumab All-Comers Phase 2 Trials
Korenblat, Phillip E., MD, FAAAAI, Hanania, Nicola A., MD, Corren, Jonathan, MD, Olssen, Julie K., MD, MS, Kamath, Nikhil, MD, Gray, Sarah, PhD, Martin, Nicolas, Holweg, Cecile T.J., PhD, Matthews, John G., MB, BS, MRSCP, PhD, Limb, Susan L., MD, Korom, Stephan
Published in Journal of allergy and clinical immunology (01.02.2016)
Published in Journal of allergy and clinical immunology (01.02.2016)
Get full text
Journal Article
Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma
Corren, Jonathan, MD, Korenblat, Phillip E., MD, Miller, Christopher J., MStat, O'Brien, Christopher D., MD, PhD, Mezzanotte, William S., MD, MPH
Published in Clinical therapeutics (01.05.2007)
Published in Clinical therapeutics (01.05.2007)
Get full text
Journal Article